DEUTSCHE BANK AG\

Bank

Position in CTMX — CytomX Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in CTMX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,486,391

+$308,313 QoQ

Shares Held

663,038

+43.1% QoQ

Ownership

0.304%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 178 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 66% Shared 0% None 34%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. CTMX ranks #95 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,486,391	663,038	+43.1%	Shares	Defined	2026-08-07
2026-03-31	$2,178,078	463,421	+1114.9%	Shares	Defined	2026-05-06
2022-03-31	$101,846	38,145	-9.9%	Shares	Defined	2022-05-13
2021-12-31	$183,257	42,323	+6.2%	Shares	Defined	2022-02-16
2021-09-30	$202,831	39,849	-1.6%	Shares	Defined	2021-11-04
2021-06-30	$256,427	40,510	-2.0%	Shares	Defined	2021-08-11
2021-03-31	$319,658	41,353	-52.6%	Shares	Defined	2021-05-13
2020-12-31	$572,004	87,329	-25.3%	Shares	Defined	2021-02-16
2020-09-30	$777,344	116,894	+92.0%	Shares	Defined	2020-11-12
2020-06-30	$507,178	60,886	+14.1%	Shares	Defined	2020-08-13
2020-03-31	$409,439	53,382	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.